CYBR breaks out of a 2nd stage flat base
CYBR appeared for the 2nd week in a row as the #1 ranked stock on ChartYourTrade's Top 10 Setups in Bases. It setup a fantastic RORO trade discussed at length on the ChartYourTrade Community page here: chartyourtrade.com/community/topic/cybr-a-potential-roro-trade/
Here is an excerpt from this weekend's analysis of CYBR:
BASE TYPE = 2nd stage base on base (latest base is a flat base)
CLASSIC PIVOT = 69.00
ADVANCED PIVOT(s) = n/a
SUPPORT = 60.30, 50dma
NOTES: CYBR attempted a breakout from the classic pivot this week but failed. It did, however, pull back to the 50dma and offer a nice RORO trade. See if the 50dma continues to hold firmly for CYBR
POINTS (+/-)
1st or 2nd Stage Base (-0)
More down weeks than up weeks (-.25)
Annual Earnings below 25% estimated increase (-.25)
ROE below 17% (-.1)
Accelerating EPS (3 quarters or more) (+.25)
Accelerating Sales (3 quarters or more) (+.25)
Group Rank 1-40 (-0)
To see the rest of today's top "Gainers on Volume" click here: chartyourtrade.com/2015/06/gainers-on-volume-as-of-06152015-cybr-vdsi-glob/
Here is an excerpt from this weekend's analysis of CYBR:
BASE TYPE = 2nd stage base on base (latest base is a flat base)
CLASSIC PIVOT = 69.00
ADVANCED PIVOT(s) = n/a
SUPPORT = 60.30, 50dma
NOTES: CYBR attempted a breakout from the classic pivot this week but failed. It did, however, pull back to the 50dma and offer a nice RORO trade. See if the 50dma continues to hold firmly for CYBR
POINTS (+/-)
1st or 2nd Stage Base (-0)
More down weeks than up weeks (-.25)
Annual Earnings below 25% estimated increase (-.25)
ROE below 17% (-.1)
Accelerating EPS (3 quarters or more) (+.25)
Accelerating Sales (3 quarters or more) (+.25)
Group Rank 1-40 (-0)
To see the rest of today's top "Gainers on Volume" click here: chartyourtrade.com/2015/06/gainers-on-volume-as-of-06152015-cybr-vdsi-glob/
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.